0538 Healthcare Resource Utilization in Treated Obstructive Sleep Apnea Patients with Comorbid Insomnia

Jean-Louis Pépin,Anita Malik,Caleb Woodford,Atul Malhotra,Kimberly Sterling,Peter Cistulli,Will McConnell,Naomi Alpert,Kate Cole
DOI: https://doi.org/10.1093/sleep/zsae067.0538
IF: 6.313
2024-04-20
SLEEP
Abstract:Abstract Introduction Insomnia and obstructive sleep apnea (OSA), comorbidly known as COMISA, are the two most common sleep disorders, with each impairing treatment efficacy for the other. Real-world studies on treatment of patients with COMISA are lacking, thus this study aimed to examine the clinical and economic impact of treating OSA with positive airway pressure (PAP) therapy in this population. Methods This retrospective study linked administrative claims data to PAP device usage data for newly diagnosed OSA patients initiating PAP (index date) between January 2015 and April 2019. Adults with evidence of insomnia (insomnia prescription fill or insomnia ICD-9/10 diagnosis code) in the year prior and in the two-year period after index were included. Inverse probability of treatment weighting and Wilcoxon rank-sum tests were used to compare healthcare resource utilization (HCRU) over 2 years across varying levels of PAP adherence. Results From a sample of 26,965 COMISA patients, 28% met the criteria for consistently-adherent, 44% were intermediately-adherent, and 28% were non-adherent to PAP therapy over 2 years after index. The majority of intermediately-adherent patients had consistent PAP use in the first year of therapy, with decreased use in the second year. Consistently-adherent patients had fewer emergency room (ER) visits per patient than intermediately-adherent patients or non-adherent patients (year 1: 0.49 vs 0.59 [P< 0.001], vs 0.68 [P< 0.001]; year 2: 0.46 vs 0.54 [P< 0.001], vs. 0.60 [P< 0.001]). Consistently-adherent patients also had fewer all-cause hospitalizations per patient than intermediately- and non-adherent patients in both follow-up years (year 1: 0.10 vs 0.15 [P< 0.001], vs. 0.14 [P< 0.001]; year 2: 0.09 vs 0.12 [P< 0.001], vs. 0.13 [P< 0.001]). Based on major diagnostic category (MDC) codes, consistently-adherent patients saw the largest reductions in hospitalizations related to the respiratory, circulatory, nervous, and hepatobiliary systems, as well as those for alcohol/drug use or induced mental disorders. Conclusion This study showed reductions in all-cause hospitalizations and ER visits for COMISA patients who were consistently-adherent to PAP therapy over 2 years compared to those with lower adherence. PAP therapy is one facet of COMISA treatment that, if adhered to, can improve health outcomes. Support (if any) ResMed
neurosciences,clinical neurology
What problem does this paper attempt to address?
Based on the provided text content, the main problems that this paper attempts to solve are as follows: 1. **Treatment compliance issues in patients with obstructive sleep apnea syndrome (OSA)**: - Research has found that although continuous positive airway pressure (PAP) therapy is the most commonly used initial treatment method for OSA patients, approximately 95.7% of patients fail to adhere to using PAP devices within 12 months after the start of treatment. This indicates that there are significant unmet needs in the current OSA treatment regimens, especially in terms of improving patient treatment compliance. 2. **Differences in PAP treatment compliance among OSA patients with different racial/ethnic backgrounds**: - The study explored the differences in PAP treatment compliance between black and Hispanic adults (B/H) and non - B/H adults through subgroup analysis. The results showed that after receiving remote monitoring interventions, the PAP treatment compliance of B/H adults was significantly improved, reaching a level similar to that of non - B/H adults. This finding emphasizes the potential value of remote monitoring interventions in improving treatment compliance in specific groups. 3. **Medical resource utilization in patients with comorbid insomnia and OSA (COMISA)**: - The study aimed to evaluate the clinical and economic impacts of PAP treatment on COMISA patients. The results showed that patients with higher PAP treatment compliance had significantly fewer emergency room visits and hospitalization rates within two years than those with lower compliance. This indicates that effective compliance with PAP treatment can significantly improve the health outcomes of COMISA patients. 4. **Predictors of driving risk in OSA patients after CPAP treatment**: - Through a multi - center prospective cohort study, the study explored the predictors of driving risk in OSA patients after CPAP treatment. The results showed that persistent drowsiness while driving and CPAP treatment compliance ≤ 4 hours/night are important indicators for predicting continuous driving risk. These findings are of great significance for clinicians and policymakers in evaluating and managing the driving risk of OSA patients. 5. **The effect of hypoglossal nerve stimulation (HNS) treatment on periodic limb movement (PLMS)**: - The study compared the PLMS situation in OSA patients before and after HNS treatment. The results showed that the incidence of PLMS increased significantly after HNS treatment, suggesting that HNS treatment may be a potential cause of PLMS. Future research is needed to further confirm this finding and explore the long - term effects of HNS treatment on PLMS and its impact on treatment effectiveness. In summary, these papers mainly focus on treatment compliance in OSA patients, treatment differences among different groups, medical resource utilization in comorbid patients, predictors of driving risk, and the impact of new treatment methods on related symptoms. These studies are helpful for optimizing the management and treatment strategies of OSA and improving the quality of life of patients.